Profund Advisors’s RAPT Therapeutics RAPT Stock Holding History

Profund Advisors’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,892	Closed	-$403K	–	1256
2025 Q4	$403K	Buy	+11,892	New	+$369K	0.01%	679
2024 Q1	–	Sell	-1,896	Closed	-$377K	–	1186
2023 Q4	$377K	Sell	1,896 -196	-9%	-$24.3K	0.02%	662
2023 Q3	$278K	Sell	2,092 -806	-28%	-$132K	0.02%	699
2023 Q2	$433K	Buy	2,898 +295	+11%	+$45.9K	0.02%	556
2023 Q1	$382K	Buy	+2,603	New	+$526K	0.02%	611

Profund Advisors's RAPT Position: Q1 2026 in Review

Profund Advisors sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 11,892 shares — an estimated $403K sold.

Profund Advisors first reported a position in RAPT in Q1 2023 and held it in 5 quarters. The position peaked at $433K in Q2 2023. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Profund Advisors reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Profund Advisors sold 11,892 RAPT Therapeutics shares in Q1 2026, an estimated $403K.
Profund Advisors first reported a position in RAPT Therapeutics in Q1 2023 and held it in 5 quarters.
Profund Advisors's RAPT Therapeutics position peaked at $433K in Q2 2023.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.